BMGL vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

BMGL

27.3
AI Score
VS
NIVF Wins

NIVF

32.4
AI Score

Investment Advisor Scores

BMGL

27score
Recommendation
AVOID NEW MONEY

NIVF

32score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BMGL NIVF Winner
Forward P/E 0 0.0015 Tie
PEG Ratio 0 0 Tie
Revenue Growth 63.0% -4.7% BMGL
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 27.3/100 32.4/100 NIVF
Profit Margin -3.5% 24.2% NIVF
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

BMGL 1M: -82.2% · 3M: -88.0% NIVF 1M: +53.8% · 3M: -45.4%

Current Technical Phase

BMGL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 19

RSI (14): 19.1 · Price: $0.68

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.7 · Price: $0.30

Fundamentals Snapshot

Metric BMGL NIVF
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.6% 0.0%
Gross Margin 0.4% 0.2%
Operating Margin 0.2% -1.8%
EPS -0.61 -34064.71
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.